HYPOTHESIS - ABERRANT PUBERTY AND THE STEIN-LEVENTHAL SYNDROME
- 1 January 1984
- journal article
- research article
- Vol. 29 (1) , 35-38
Abstract
The Stein-Leventhal syndrome (type 1 polycystic ovarian disease: SLS-PCOD-I) results from an aberrant puberty. Abnormal neural development in the brain decreases the hypophyseal set-point for negative and positive ovarian hormone feedback. This generates a condition whereby hypophyseal luteinizing hormone (LH) secretion is inappropriately elevated compared to hypophyseal (FSH) secretion and is thus termed inappropriate gonadotropin secretion (IGS). The events which create an initial state of IGS are referred to as the generator stage. IGS is maintained by ovarian-derived hyperandrogenemia and increased peripheral aromatization of androgens yielding elevated free serum estrone (E1) and unbound estradiol (E2) levels. E1 suppresses release of hypophyseal FSH while E2 exerts positive feedback on LH pulsatile release by increasing pituitary sensitivity to gonadotropin-releasing hormone (GnRH). Diminished circulating FSH levels decrease granulosa cell aromatase activity sufficiently to cause suboptimal ovarian conversion of LH-induced thecal androgens into estrogens. Consequently, chronic local ovarian hyperandrogenemia with associated arrested follicle maturation results in chronic anovulation. An elevated circulating LH/FSH ratio stimulates early development and proliferation of immature follicles causing the appearance of polyfollicular ovaries. In this effector stage of PCOD-I, a vicious cycle is fashioned wherein IGS causes polyfollicular ovaries and increased ovarian androgen production which, in turn, promotes IGS. The etiology of this disease could involve an aberrant puberty that establishes a persistent faulty hypothalamic-hypophyseal-ovarian axis.This publication has 14 references indexed in Scilit:
- Increased Luteinizing Hormone Sensitivity to Dopamine Inhibition in Polycystic Ovary Syndrome*Journal of Clinical Endocrinology & Metabolism, 1981
- ELEVATIONS IN UNBOUND SERUM ESTRADIOL AS A POSSIBLE MECHANISM FOR INAPPROPRIATE GONADOTROPIN SECRETION IN WOMEN WITH PCO1Journal of Clinical Endocrinology & Metabolism, 1981
- Inhibin: Differences in Bioactivity within Human Follicular Fluid in the Follicular and Luteal Stages of the Menstrual CycleExperimental Biology and Medicine, 1980
- Functional Studies of Aromatase Activity in Human Granulosa Cells from Normal and Polycystic Ovaries*Journal of Clinical Endocrinology & Metabolism, 1979
- Pituitary Tumors Associated with Hyperprolactinemia and Polycystic Ovarian DiseaseFertility and Sterility, 1979
- Promotion of human adipocyte precursor replication by 17beta-estradiol in culture.Journal of Clinical Investigation, 1978
- Pituitary response to bolus and continuous intravenous infusion of luteinizing hormone-releasing factor in normal women and women with polycystic ovarian syndromeAmerican Journal of Obstetrics and Gynecology, 1978
- SUPPRESSION OF SERUM FOLLICLE STIMULATING HORMONE IN INTACT AND ACUTELY OVARIECTOMIZED RATS BY PORCINE FOLLICULAR FLUIDEndocrinology, 1977
- Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.Journal of Clinical Investigation, 1976
- Luteinization of the Ovarian Theca in Infants and ChildrenAmerican Journal of Clinical Pathology, 1962